Search results for: Chronic Diseases
Filter search results
Understanding the Full Value of Long-Acting Therapies: less is more?
7 May 2025
…This will incentivise innovation, ensure equitable patient access, and support sustainable investments in transformative treatments for chronic disease management. Share this: Download publication These therapies are particularly effective for chronic…
The changing role of the NHS over time
14 August 2023
…in 2040: projected patterns of illness in England. [online] Available at: https://www.health.org.uk/publications/health-in-2040 [Accessed 14 Aug. 2023]. World Health Organization, 2022. Noncommunicable diseases. [online] Available at: https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases [Accessed 21 Jun. 2023]….
Rare Disease Day 2022
28 February 2022
World Rare Disease Day aims to raise awareness of rare diseases and the impact they can have on patients. This blog explores OHE’s contributions to research into rare diseases and…
An eye on sustainability at the Economist’s Future of Health Europe
30 October 2023
…billion dollars are spent annually on managing non-communicable diseases, such as diabetes, heart disease, and cancer. These diseases are largely preventable, and often linked to environmental factors, such as air…
Using MCDA to Assess the Value of Treatments for Rare Diseases
5 December 2013
…effects for rare diseases than for other diseases. Payers recognise that a different approach may be needed to determine reimbursement eligibility and levels for rare disease treatments. To explore one…
PROMs and Choice in the NHS
30 March 2010
…health care is not easy. Many once-deadly diseases have been transformed into chronic diseases, making measures of mortality very poor indicators of value for most diseases. Clinical outcomes can offer…
NICE’s severity modifier: a step in the right direction, but still a long way to go
23 March 2022
…by people living with the disease. Younger individuals have a greater number of potential future QALYs to lose on average and therefore severe chronic diseases that affect younger patient populations…
CBO Doesn’t Capture The Real Impact of H.R. 3 on Innovation
14 September 2021
…a reduction in the average target patient population size. In 2020, 58% of new approvals were for rare or orphan diseases. Molecular and genetic techniques allow better stratification of diseases…
Just Published: Systematic Review of Utility Weights Used in Economic Evaluations of Vaccines for Paediatric Infectious Diseases
21 April 2016
…recently been published in Value in Health, which reports a systematic review of the sources and characteristics of utility weights used to assess the cost-effectiveness of vaccines for infectious diseases…